Editas Medicine, Inc.
EDIT
$2.35
-$0.11-4.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.74M | 7.54M | 3.58M | 4.66M | 30.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.74M | 7.54M | 3.58M | 4.66M | 30.60M |
| Cost of Revenue | 27.40M | 19.78M | 16.18M | 26.59M | 48.61M |
| Gross Profit | -2.66M | -12.23M | -12.60M | -21.94M | -18.01M |
| SG&A Expenses | 11.35M | 12.32M | 12.86M | 13.38M | 16.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.76M | 32.09M | 29.04M | 39.97M | 64.97M |
| Operating Income | -14.02M | -24.55M | -25.46M | -35.31M | -34.36M |
| Income Before Tax | -5.62M | -25.12M | -53.24M | -76.09M | -45.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.62M | -25.12M | -53.24M | -76.09M | -45.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.62M | -25.12M | -53.24M | -76.09M | -45.40M |
| EBIT | -14.02M | -24.55M | -25.46M | -35.31M | -34.36M |
| EBITDA | -13.21M | -23.83M | -23.63M | -33.39M | -31.19M |
| EPS Basic | -0.06 | -0.28 | -0.63 | -0.92 | -0.55 |
| Normalized Basic EPS | -0.06 | -0.17 | -0.20 | -0.27 | -0.25 |
| EPS Diluted | -0.06 | -0.28 | -0.63 | -0.92 | -0.55 |
| Normalized Diluted EPS | -0.06 | -0.17 | -0.20 | -0.27 | -0.25 |
| Average Basic Shares Outstanding | 97.26M | 90.09M | 84.41M | 83.06M | 82.61M |
| Average Diluted Shares Outstanding | 97.26M | 90.09M | 84.41M | 83.06M | 82.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |